Matthew V. Rudorfer

3.9k total citations
62 papers, 2.0k citations indexed

About

Matthew V. Rudorfer is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Matthew V. Rudorfer has authored 62 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmacology, 29 papers in Psychiatry and Mental health and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Matthew V. Rudorfer's work include Treatment of Major Depression (29 papers), Electroconvulsive Therapy Studies (17 papers) and Bipolar Disorder and Treatment (16 papers). Matthew V. Rudorfer is often cited by papers focused on Treatment of Major Depression (29 papers), Electroconvulsive Therapy Studies (17 papers) and Bipolar Disorder and Treatment (16 papers). Matthew V. Rudorfer collaborates with scholars based in United States, Czechia and Canada. Matthew V. Rudorfer's co-authors include William Z. Potter, William Z. Potter, Markku Linnoila, Hans Ågren, Ivan N. Mefford, Husseini K. Manji, Alastair J.J. Wood, John A. Oates, Markku Linnoila and Herbert Weingartner and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Matthew V. Rudorfer

61 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew V. Rudorfer United States 25 826 639 404 349 281 62 2.0k
John J. Sramek United States 28 829 1.0× 844 1.3× 413 1.0× 311 0.9× 167 0.6× 120 2.8k
Thomas L. Schwartz United States 27 689 0.8× 476 0.7× 290 0.7× 360 1.0× 274 1.0× 79 2.3k
Paul J. Goodnick United States 31 1.4k 1.7× 777 1.2× 369 0.9× 474 1.4× 233 0.8× 91 3.2k
Nathan Herrmann Canada 25 779 0.9× 592 0.9× 440 1.1× 233 0.7× 445 1.6× 62 3.2k
L. F. Gram Denmark 26 859 1.0× 1.2k 1.8× 266 0.7× 238 0.7× 204 0.7× 54 3.0k
Trevor Silverstone United Kingdom 34 1.6k 2.0× 629 1.0× 634 1.6× 732 2.1× 190 0.7× 132 3.5k
Y.D. Lapierre Canada 27 1.1k 1.4× 560 0.9× 741 1.8× 521 1.5× 227 0.8× 139 2.6k
D. Sechter France 31 1.7k 2.1× 661 1.0× 617 1.5× 698 2.0× 303 1.1× 85 3.2k
Anna Åberg‐Wistedt Sweden 23 714 0.9× 379 0.6× 256 0.6× 582 1.7× 221 0.8× 38 1.7k
Sanjay Dubé United States 20 1.4k 1.7× 847 1.3× 449 1.1× 242 0.7× 286 1.0× 48 2.6k

Countries citing papers authored by Matthew V. Rudorfer

Since Specialization
Citations

This map shows the geographic impact of Matthew V. Rudorfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew V. Rudorfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew V. Rudorfer more than expected).

Fields of papers citing papers by Matthew V. Rudorfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew V. Rudorfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew V. Rudorfer. The network helps show where Matthew V. Rudorfer may publish in the future.

Co-authorship network of co-authors of Matthew V. Rudorfer

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew V. Rudorfer. A scholar is included among the top collaborators of Matthew V. Rudorfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew V. Rudorfer. Matthew V. Rudorfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bingham, Kathleen, Ellen M. Whyte, Benoit H. Mulsant, et al.. (2019). Health-related quality of life in remitted psychotic depression✰. Journal of Affective Disorders. 256. 373–379. 2 indexed citations
2.
Flint, Alastair J., Barnett S. Meyers, Anthony J. Rothschild, et al.. (2019). Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission. JAMA. 322(7). 622–622. 43 indexed citations
3.
Sanislow, Charles A., Michele Ferrante, Jennifer Pacheco, Matthew V. Rudorfer, & Sarah E. Morris. (2019). Advancing Translational Research Using NIMH Research Domain Criteria and Computational Methods. Neuron. 101(5). 779–782. 67 indexed citations
4.
5.
McCall, W. Vaughn, Sarah H. Lisanby, Peter B. Rosenquist, et al.. (2017). Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients. The Journal of Clinical Psychiatry. 79(2). 78–84. 2 indexed citations
6.
McCall, W. Vaughn, Sarah H. Lisanby, Peter B. Rosenquist, et al.. (2016). Effects of a right unilateral ultrabrief pulse electroconvulsive therapy course on health related quality of life in elderly depressed patients. Journal of Affective Disorders. 209. 39–45. 7 indexed citations
7.
Rudorfer, Matthew V. & William Z. Potter. (1999). Metabolism of Tricyclic Antidepressants. Cellular and Molecular Neurobiology. 19(3). 373–409. 86 indexed citations
8.
Rudorfer, Matthew V. & William Z. Potter. (1997). The Role of Metabolites of Antidepressants in the Treatment of Depression. CNS Drugs. 7(4). 273–312. 39 indexed citations
9.
Rudorfer, Matthew V., et al.. (1993). Biogemic amines in seasonal affective disorder: Effects of light therapy. Psychiatry Research. 46(1). 19–28. 30 indexed citations
10.
Manji, Husseini K., John Hsiao, Emile D. Risby, et al.. (1992). ECT treatment does not enhance neuroendocrine responses to serotonergic challenge. Journal of Psychopharmacology. 6(4). 501–508. 2 indexed citations
11.
Rudorfer, Matthew V., H.K. Manji, & W.Z. Potter. (1992). MONOAMINERGIC ACTIONS OF ECT. Clinical Neuropharmacology. 15. 677A–678A. 6 indexed citations
12.
Rudorfer, Matthew V., Emile D. Risby, Ossama T. Osman, Philip W. Gold, & William Z. Potter. (1991). Hypothalamic-pituitary-adrenal axis and monoamine transmitter activity in depression: A pilot study of central and peripheral effects of electroconvulsive therapy. Biological Psychiatry. 29(3). 253–264. 25 indexed citations
13.
Oates, John A., Alastair J.J. Wood, William Z. Potter, Matthew V. Rudorfer, & Husseini K. Manji. (1991). The Pharmacologic Treatment of Depression. New England Journal of Medicine. 325(9). 633–642. 163 indexed citations
14.
Rudorfer, Matthew V.. (1989). Unilateral ECT: Medications and Monitoring. American Journal of Psychiatry. 146(2). 285–a. 1 indexed citations
15.
Buckholtz, Neil, Albert O. Davies, Matthew V. Rudorfer, Robert N. Golden, & William Z. Potter. (1988). Lymphocyte beta adrenergic receptor function versus catecholamines in depression. Biological Psychiatry. 24(4). 451–457. 9 indexed citations
16.
Rudorfer, Matthew V., Markku Linnoila, & William Z. Potter. (1987). Accidental Antidepressants: Search for Specific Action. PubMed. 3. 157–166. 5 indexed citations
17.
Rudorfer, Matthew V., Farouk Karoum, Richard Ross, William Z. Potter, & Markku Linnoila. (1985). Differences in lithium effects in depressed and healthy subjects. Clinical Pharmacology & Therapeutics. 37(1). 66–71. 12 indexed citations
18.
Rudorfer, Matthew V. & William Z. Potter. (1985). Advances in psychopharmacology: Predicting and improving treatment response. Psychiatry Research. 14(1). 95–96. 5 indexed citations
19.
Spiegel, Allen M., Matthew V. Rudorfer, Stephen J. Marx, & Markku Linnoila. (1984). The Effect of Short Term Lithium Administration on Suppressibility of Parathyroid Hormone Secretion by Calciumin Vivo. The Journal of Clinical Endocrinology & Metabolism. 59(2). 354–357. 16 indexed citations
20.
Rudorfer, Matthew V. & Eli Robins. (1981). Fatal nortriptyline overdose, plasma levels, and in vivo methylation of tricyclic antidepressants. American Journal of Psychiatry. 138(7). 982–983. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John J. Sramek Breakdown of academic impact, for papers by Thomas L. Schwartz Breakdown of academic impact, for papers by Paul J. Goodnick Breakdown of academic impact, for papers by Nathan Herrmann Breakdown of academic impact, for papers by L. F. Gram Breakdown of academic impact, for papers by Trevor Silverstone Breakdown of academic impact, for papers by Y.D. Lapierre Breakdown of academic impact, for papers by D. Sechter Breakdown of academic impact, for papers by Anna Åberg‐Wistedt Breakdown of academic impact, for papers by Sanjay Dubé
Rankless by CCL
2026